The Toronto Stock Exchange reports that Trillium Therapeutics Inc. will list additional shares at the open on Feb. 28, 2019. According to the TSX, the listing will cover shares to be issued pursuant to a prospectus supplement dated Feb. 22, 2019.
As stated in the prospectus, the company will issue 6.55 million units at 80 U.S. cents per unit in an offering. Each unit will consist of one share and one share purchase warrant. Each warrant will be exercisable at 96 U.S. cents per share for five years after the closing of the offering, subject to acceleration.
According to the TSX, the units will separate immediately upon the closing of the offering. The warrants will not be listed and posted for trading on the TSX.
© 2020 Canjex Publishing Ltd. All rights reserved.